GSK - GlaxoSmithKline plc (GSK) Management Presents at Citi's 16th Annual BioPharma Virtual Conference (Transcript)

GlaxoSmithKline plc (GSK) Citi's 16th Annual BioPharma Virtual Conference September 09, 2021 01:25 PM ET Company Participants Kimberly Smith - Head of R&D, ViiV Conference Call Participants Andrew Baum - Citi Presentation Andrew Baum Good afternoon. Delighted that you could join the GSK web session. My name is Andrew Baum. I'm delighted to be joined by Dr. Kimberly Smith, the Head of R&D at ViiV. Thank you so much for joining us today. We've also got Frannie DeFranco from GSK’s IR on the call with us. So look we've got about 45 minutes to talk to what is really a critical part of GSK's business not just in the fact it's serving an important unmet need. But from a contribution economically because of the very high contribution margin it counted well above the wages of the new revenue contribution. So it's one that merits a lot of focus. Now perhaps

For further details see:

GlaxoSmithKline plc (GSK) Management Presents at Citi's 16th Annual BioPharma Virtual Conference (Transcript)